BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 1376783)

  • 21. Comparison of angiotensin-converting enzyme inhibitors in the rat in perfused hindlimbs and in vivo.
    Nelissen-Vrancken MH; Leenders PJ; Bost JG; Struijker-Boudier HA; Smits JF
    Eur J Pharmacol; 1992 Jun; 217(1):49-55. PubMed ID: 1327817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentoxifylline treatment enhances antihypertensive activity of captopril through hemorheological improvement in spontaneously hypertensive rats during development of arterial hypertension.
    Plotnikov MB; Shamanaev AY; Aliev OI; Sidekhmenova AV; Anishchenko AM; Arkhipov AM
    J Am Soc Hypertens; 2017 Nov; 11(11):769-778. PubMed ID: 28989072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
    van den Broek SA; de Graeff PA; Smit AJ; Girbes AR; Journée ; van Gilst WH; Hillege H; van Veldhuisen DJ; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
    Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
    Jackson EK; Herzer WA; Mi Z; Vyas SJ; Kost CK
    J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
    Haddad G; Garcia R
    J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.
    Richer C; Doussau MP; Giudicelli JF
    Hypertension; 1983; 5(3):312-20. PubMed ID: 6188693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
    Zimmerman BG; Goering JL; Raich PC
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
    Zhang X; Dunham EW; Zimmerman BG
    J Hypertens; 1995 Dec; 13(12 Pt 1):1413-19. PubMed ID: 8866903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
    Castro-Moreno P; Pardo JP; Hernández-Muñoz R; López-Guerrero JJ; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M; Villalobos-Molina R
    Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):61-9. PubMed ID: 22994939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
    Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM
    Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a captopril-sensitive angiotensin converting enzyme in the hindquarter vasculature of SHR and WKY.
    Mueller SM; Cohen ML
    Artery; 1985; 12(6):337-45. PubMed ID: 2996465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
    Kost CK; Herzer WA; Li P; Jackson EK
    J Pharmacol Exp Ther; 1994 Apr; 269(1):82-8. PubMed ID: 8169855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.
    Jin H; Yang R; Gillett N; Clark RG; Ko A; Paoni NF
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):420-5. PubMed ID: 8583784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the angiotensin I converting enzyme inhibitor perindopril on cerebral blood flow in awake hypertensive rats.
    Bray L; Lartaud I; Muller F; Atkinson J; Capdeville C
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):246S-252S. PubMed ID: 2043313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS
    J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effects of acute and chronic treatment with aladotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, in conscious rats with myocardial infarction.
    Marie C; Mossiat C; Lecomte JM; Schwartz JC; Bralet J
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1324-31. PubMed ID: 8531099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.